All Posts By

Smartkarma Daily Briefs

Daily Brief ECM: ATRenew (RERE US): Pre-Owned Satisfaction and more

By | Daily Briefs, ECM

In today’s briefing:

  • ATRenew (RERE US): Pre-Owned Satisfaction
  • DPC Dash IPO: Dominos Getting Dominated
  • Weilong Delicious Global IPO – Tepid Recent Performance Still Makes It Look Expensive
  • Weilong Delicious IPO: Valuation Insights
  • Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers

ATRenew (RERE US): Pre-Owned Satisfaction

By Arun George

  • ATRenew (RERE US) operates the largest pre-owned consumer electronics transactions and services platform in China. It is listed in June 2021 at US$14 per ADS. 
  • The shares are down 63% YTD largely due to the tech market sell-off. Unlike most tech companies, ATRenew is starting to deliver growth with profits, cash generation and share buybacks.
  • The valuation is undemanding compared to a peer group of pre-owned marketplaces and global online retail marketplaces. It will also appeal to investors with an ESG mandate.

DPC Dash IPO: Dominos Getting Dominated

By Oshadhi Kumarasiri

  • DPC Dash (DPC HK) is the exclusive master franchisee of Domino’s Pizza (DPZ US) in mainland China, Hong Kong and Macau with around 546 stores as of 9M2022.
  • The company has refiled for an IPO on the Hong Kong Stock Exchange after failing the first time to raise around US $100m in March 2022.
  • Discounted pricing has failed to propel the Dominos brand to the top in many Asian markets where pizza is considered a luxury meal. DPC-Dash is experiencing the same in China.

Weilong Delicious Global IPO – Tepid Recent Performance Still Makes It Look Expensive

By Sumeet Singh

  • Weilong Delicious Global (WDG HK)  a spicy snack food company in China, aims to raise around US$140m in its Hong Kong IPO.
  • According to F&S, WDG ranked first among spicy snack food enterprises in China, with a market share of 6.2%, and in the seasoned flour product and spicy vegetable snacks categories.
  • We have covered various aspects of the deal in our previous notes, in this note, we will talk about  the final valuations.

Weilong Delicious IPO: Valuation Insights

By Arun George


Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers

By Baptista Research

  • This is our first report on Baxter International, one of the largest players in the domain of dialysis therapies and other healthcare products.
  • The overall demand for products across the Baxter and traditional Hillrom portfolios continues to be strong.
  • We initiate coverage on the stock of Baxter International with a ‘Buy’ rating.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Equity Bottom-Up: Smartkarma Webinar | Top Indian Equity Picks and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Smartkarma Webinar | Top Indian Equity Picks
  • China Internet Weekly (5Dec2022): JD.com, Baidu, IQiyi, Alibaba Health, ZTO, Pinduoduo, KE
  • Meituan (3690 HK): 3Q22, Growth Higher, Loss Close to Zero, 90% Upside
  • Aneka Gas (AGII IJ) – Out of Thin Air
  • Bilibili: Earnings Recovery to Continue with Improvement in Mobile Games and Cost Controls
  • Daifuku (6383) | Attractive Valuation Drivers Despite near Term Risks
  • ATRenew: A Turnaround Story With Material Increase in Profit Margins + Remaining Share Buyback
  • A Profitable Japanese Microcap Trading at a 53% Discount to NCAV.
  • NTGR: Routing Thru Investor Day
  • ATRenew: Round & Round It Goes

Smartkarma Webinar | Top Indian Equity Picks

By Smartkarma Research

In the next webinar, we welcome Smartkarma Insight Provider Gauri Anand , who will be sharing with us her Top indian Equity Picks and the investment philosophy behind each of her picks. Have any burning questions about companies like Indian Energy Exchange (IEX IN), VA Tech Wabag (VATW IN), or UPL Ltd (UPLL IN)? Get them answered in the live Q&A that will conclude the session.

The webinar will be hosted on Wednesday, 21 December 2022, 17:00 SGT/HKT.

Gauri Anand is a mid-small cap specialist based in India. With a focus on equities, Gauri combs top down and bottom up approaches to identify themes and value stocks at its inflexion point. Sector agnostic with a value oriented – Inflexion approach, Gauri dives into bottom Up ideas with a biased towards Sustainability and ESG. 


China Internet Weekly (5Dec2022): JD.com, Baidu, IQiyi, Alibaba Health, ZTO, Pinduoduo, KE

By Ming Lu

  • Richard Liu came back to manage JD.com after he resigned half a year ago.
  • Alibaba Health revenue increased 23% YoY in 1H23, which benefited from hospitals being closed.
  • Pinduoduo revenue increased by 65% YoY and operating profit increased 388% YoY in 3Q22.

Meituan (3690 HK): 3Q22, Growth Higher, Loss Close to Zero, 90% Upside

By Ming Lu

  • The revenue growth rate accelerated to 28% YoY in 3Q22 versus 16% YoY in 2Q22.
  • Operating Loss was close to zero in 3Q22 and we believe it will turn positive in 2023.
  • According to price / sales history, we believe the company has an upside of 89% for year end 2023.

Aneka Gas (AGII IJ) – Out of Thin Air

By Angus Mackintosh

  • Aneka Gas is an interesting concept in that its product literally comes out of thin air given its position as Indonesia’s leading Industrial gas player with a 45% market share.
  • The company provides investors with wide-ranging exposure to the Indonesian economy from industry to infrastructure, consumer goods, healthcare, and SME amongst others, which also reduces risk through diversity.
  • Aneka Gas 9M2022 numbers reflected a change in revenue mix and demand for medical gas reduces post-COVID and other areas such as industry, retail, and infrastructure started to recover.

Bilibili: Earnings Recovery to Continue with Improvement in Mobile Games and Cost Controls

By Shifara Samsudeen, ACMA, CGMA

  • Bilibili Inc (BILI US) reported 3Q2022 results Tuesday. 3Q revenue increased 11.3% YoY to RMB5.8bn (vs consensus RMB5.7bn) while operating losses for the quarter dropped to RMB1.8bn vs consensus RMB2.1bn.
  • Recovery in mobile games biz alongside aggressive cost cutting measures supported improvement in Bilibili’s profitability during the quarter.
  • Pandaily reported that Bilibili is exploring expanding into the SEA region and increased R&D spending could be an indication that plans are underway.  

Daifuku (6383) | Attractive Valuation Drivers Despite near Term Risks

By Mark Chadwick

  • Daifuku is a growth stock that has fallen by 26% YTD reflecting near term risks to growth and margins
  • We believe that Daifuku is a major beneficiary of continued investment in automation, especially in e-commerce and logistics
  • We analyse Daifuku’s core valuation drivers and see around 16% upside for the stock

ATRenew: A Turnaround Story With Material Increase in Profit Margins + Remaining Share Buyback

By Douglas Kim

  • ATRenew (RERE US) is one of the stocks in China that is starting to look very attractive after a sharp decline in its share price since its IPO.
  • ATRenew has achieved noticeable improvements in operations and profitability in the recent quarter.
  • Our base case valuation analysis suggests an implied market cap of US$720 million, representing an implied price of US$3.15 per share, representing an upside of 43% from current price.

A Profitable Japanese Microcap Trading at a 53% Discount to NCAV.

By Generals and Workouts

  • The cash comes from a one-off asset sale. CEL hasn’t been building cash on the balance sheet for years. While management has no intention of paying out the cash at present, they plan to use it for acquisitions. It won’t stay on the balance sheet for ever.

  • CEL’s operating business is not a great business, but it’s not terrible either. CEL earned an average of 15% pretax on capital employed over the last three years (FY20-FY22). The operating business earns above its cost of capital, is consistently profitable and ~40% of earnings are paid out as dividends.

  • Management has a lot of skin in the game. CEL’s founder and president, Masatsugu Shinno, owns 60% of the company, which aligns his interests with shareholders.


NTGR: Routing Thru Investor Day

By Hamed Khorsand

  • NTGR held its annual investor day reflecting on the challenges it has incurred within retail and highlighting how consumer demand has remained strong for high-end devices and its 5G hotspot
  • NTGR’s stock has been trading at levels valuing the Company near its working capital on fears the business would continue to generate losses
  • NTGR’s transition in becoming a super-premium brand started over a year ago, but only in recent quarters has it began to take a bigger role on the consumer 

ATRenew: Round & Round It Goes

By David Blennerhassett

  • JD.com Inc. (9618 HK)-backed ATRenew (RERE US), one of the pioneers of China’s circular economy, registered its first non-GAAP net profit in the 3Q22.
  • The improvement pivoted off core business stability (consumer electronic devices recycling and sales) and an increasing revenue stream from its multi-category recycling business, including luxury goods.
  • This is all positive. However ATR, like all US-listed China plays, faces the prospect of a potential delisting under the HFCAA just 16 months away.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Event-Driven: Where Does Melco’s Discount To NAV Go From Here? and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Where Does Melco’s Discount To NAV Go From Here?
  • Nippon Prologis REIT (3283 JP): Offering Could Be a Catalyst for Outperformance Vs Peers
  • HSCEI Index Rebalance Preview: Shenhua Energy (1088) Could Replace China Feihe (6186)
  • KOSPI 200 Passive Flow Breakdown, Feat. NPS Size & Trade Window Pattern
  • Star Health IPO Lockup – Owned by Financial Investors, US$3.0bn Worth Shares Are Well in the Money

Where Does Melco’s Discount To NAV Go From Here?

By David Blennerhassett


Nippon Prologis REIT (3283 JP): Offering Could Be a Catalyst for Outperformance Vs Peers

By Janaghan Jeyakumar, CFA

  • Japan’s largest logistics REIT Nippon Prologis Reit (3283 JP) (“NPR”) announced a US$170mn follow-on equity offering to fund their recent acquisition of three logistics facilities.
  • The primary offer quantity will be 76,570 units out of which 44,410 units and 32,160 units are expected to be allocated for domestic and international investors, respectively. 
  • Below is a closer look at the details of this offering and the potential of this offering to trigger strong secondary market performance in the following weeks.

HSCEI Index Rebalance Preview: Shenhua Energy (1088) Could Replace China Feihe (6186)

By Brian Freitas


KOSPI 200 Passive Flow Breakdown, Feat. NPS Size & Trade Window Pattern

By Sanghyun Park

  • We should set the minimum level of the target size to estimate the flow impact on T-1 Effective at ₩15T from ETFs.
  • We then need to pay attention to the recent trend that an additional flow from NPS appears post-Effective, with a significant portion on T+1~3.
  • We should revise down our expected rate of return on our early-phase setup aiming at the preemptive trading (T-6W Effective) by NPS.

Star Health IPO Lockup – Owned by Financial Investors, US$3.0bn Worth Shares Are Well in the Money

By Sumeet Singh

  • In Dec 2021, Star Health (STARHEAL IN) (SHAI), the largest private health and retail health insurance company in India, raised around US$851m in its India IPO.
  • SHAI insured 20.5m people in FY21. SHAI primarily offers retail health insurance which accounted for 87.9% of its FY21 GWP. Individual agents accounted for 97% of its FY21 GWP.
  • In this note, we will talk about the upcoming lockup expiry.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Macro: The Week That Was in ASEAN@Smartkarma – Adaro Beyond Coal and more

By | Daily Briefs, Macro

In today’s briefing:

  • The Week That Was in ASEAN@Smartkarma – Adaro Beyond Coal, Indocement, and SingTel Back in Favour?
  • Anwar’s Cabinet Deftly Balances Policy and Political Imperatives
  • The Commodity Report #80
  • The Mountains are high….

The Week That Was in ASEAN@Smartkarma – Adaro Beyond Coal, Indocement, and SingTel Back in Favour?

By Angus Mackintosh


Anwar’s Cabinet Deftly Balances Policy and Political Imperatives

By Manu Bhaskaran

  • Anwar’s cabinet reflects the complex realities of governing via a coalition of unlikely bedfellows. Compromises had to be made. 
  • Assigning influential posts to UMNO’s pro-coalition faction helps ensure Barisan’s continued support for the coalition. GPS’ expanded cabinet presence should keep it satisfied.
  • Appointments to key economics-related portfolios are a cause for cautious optimism that economic policymaking will be sound and rational.

The Commodity Report #80

By The Commodity Report

  • US manufacturing contracted in November for the first time since May 2020 as output weakened in the face of a third-straight month of shrinking orders.
  • According to data released Thursday, the ISM’s gauge of factory activity slid to 49 from 50.2 in the prior month.
  • The measure has fallen in five of the last six months and stands below 50, the threshold separating expansion and contraction, for the first time since the pandemic lockdowns.

The Mountains are high….

By Mark Tinker

  • There is a tendency in the west to see China as an authoritarian monolith – in contrast to the supposedly highly accountable democratic west, albeit only those with the shortest of memories can look at the current protests against Covid taking place in China and think them somehow unique*.
  • The reality is, of course, different, for while over the course of his first two terms Xi has certainly moved to consolidate more power to the centre, the reality is still that, in the words of the old Chinese proverb, “The mountains are high and the Emperor is far away”, ie the relative autonomy of the regions remains strong and thus the Covid restrictions – and by extension the protests – reflect a tapestry of different regional interpretations of central government policies.
  • Right now, it seems that the centre is asking the regions to ease back on Covid restrictions, which is why, despite the headlines, the markets believe this is more about opening up than closing down again. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Energy/Materials: Indian Energy Exchange Ltd, China Shenhua Energy Co H, ABM Investama, Crude Oil and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Smartkarma Webinar | Top Indian Equity Picks
  • HSCEI Index Rebalance Preview: Shenhua Energy (1088) Could Replace China Feihe (6186)
  • Asia HY Monthly – November 2022 – Lucror Analytics
  • The Commodity Report #80

Smartkarma Webinar | Top Indian Equity Picks

By Smartkarma Research

In the next webinar, we welcome Smartkarma Insight Provider Gauri Anand , who will be sharing with us her Top indian Equity Picks and the investment philosophy behind each of her picks. Have any burning questions about companies like Indian Energy Exchange (IEX IN), VA Tech Wabag (VATW IN), or UPL Ltd (UPLL IN)? Get them answered in the live Q&A that will conclude the session.

The webinar will be hosted on Wednesday, 21 December 2022, 17:00 SGT/HKT.

Gauri Anand is a mid-small cap specialist based in India. With a focus on equities, Gauri combs top down and bottom up approaches to identify themes and value stocks at its inflexion point. Sector agnostic with a value oriented – Inflexion approach, Gauri dives into bottom Up ideas with a biased towards Sustainability and ESG. 


HSCEI Index Rebalance Preview: Shenhua Energy (1088) Could Replace China Feihe (6186)

By Brian Freitas


Asia HY Monthly – November 2022 – Lucror Analytics

By Charles Macgregor

The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks. The Asia Monthly is intended to broaden investors’ understanding of the Asian USD high-yield market.


The Commodity Report #80

By The Commodity Report

  • US manufacturing contracted in November for the first time since May 2020 as output weakened in the face of a third-straight month of shrinking orders.
  • According to data released Thursday, the ISM’s gauge of factory activity slid to 49 from 50.2 in the prior month.
  • The measure has fallen in five of the last six months and stands below 50, the threshold separating expansion and contraction, for the first time since the pandemic lockdowns.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Aneka Gas, Daifuku Co Ltd, CEL Corp and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Aneka Gas (AGII IJ) – Out of Thin Air
  • Daifuku (6383) | Attractive Valuation Drivers Despite near Term Risks
  • A Profitable Japanese Microcap Trading at a 53% Discount to NCAV.

Aneka Gas (AGII IJ) – Out of Thin Air

By Angus Mackintosh

  • Aneka Gas is an interesting concept in that its product literally comes out of thin air given its position as Indonesia’s leading Industrial gas player with a 45% market share.
  • The company provides investors with wide-ranging exposure to the Indonesian economy from industry to infrastructure, consumer goods, healthcare, and SME amongst others, which also reduces risk through diversity.
  • Aneka Gas 9M2022 numbers reflected a change in revenue mix and demand for medical gas reduces post-COVID and other areas such as industry, retail, and infrastructure started to recover.

Daifuku (6383) | Attractive Valuation Drivers Despite near Term Risks

By Mark Chadwick

  • Daifuku is a growth stock that has fallen by 26% YTD reflecting near term risks to growth and margins
  • We believe that Daifuku is a major beneficiary of continued investment in automation, especially in e-commerce and logistics
  • We analyse Daifuku’s core valuation drivers and see around 16% upside for the stock

A Profitable Japanese Microcap Trading at a 53% Discount to NCAV.

By Generals and Workouts

  • The cash comes from a one-off asset sale. CEL hasn’t been building cash on the balance sheet for years. While management has no intention of paying out the cash at present, they plan to use it for acquisitions. It won’t stay on the balance sheet for ever.

  • CEL’s operating business is not a great business, but it’s not terrible either. CEL earned an average of 15% pretax on capital employed over the last three years (FY20-FY22). The operating business earns above its cost of capital, is consistently profitable and ~40% of earnings are paid out as dividends.

  • Management has a lot of skin in the game. CEL’s founder and president, Masatsugu Shinno, owns 60% of the company, which aligns his interests with shareholders.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: Meituan, Bilibili Inc, ATRenew, Netgear Inc, Hon Hai Precision Industry and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Meituan (3690 HK): 3Q22, Growth Higher, Loss Close to Zero, 90% Upside
  • Bilibili: Earnings Recovery to Continue with Improvement in Mobile Games and Cost Controls
  • ATRenew: A Turnaround Story With Material Increase in Profit Margins + Remaining Share Buyback
  • NTGR: Routing Thru Investor Day
  • Taiwan Tech Weekly: Hon Hai IPhone Plant Recovery, Nanya Slumps, Intel Foundry Potential in 2023

Meituan (3690 HK): 3Q22, Growth Higher, Loss Close to Zero, 90% Upside

By Ming Lu

  • The revenue growth rate accelerated to 28% YoY in 3Q22 versus 16% YoY in 2Q22.
  • Operating Loss was close to zero in 3Q22 and we believe it will turn positive in 2023.
  • According to price / sales history, we believe the company has an upside of 89% for year end 2023.

Bilibili: Earnings Recovery to Continue with Improvement in Mobile Games and Cost Controls

By Shifara Samsudeen, ACMA, CGMA

  • Bilibili Inc (BILI US) reported 3Q2022 results Tuesday. 3Q revenue increased 11.3% YoY to RMB5.8bn (vs consensus RMB5.7bn) while operating losses for the quarter dropped to RMB1.8bn vs consensus RMB2.1bn.
  • Recovery in mobile games biz alongside aggressive cost cutting measures supported improvement in Bilibili’s profitability during the quarter.
  • Pandaily reported that Bilibili is exploring expanding into the SEA region and increased R&D spending could be an indication that plans are underway.  

ATRenew: A Turnaround Story With Material Increase in Profit Margins + Remaining Share Buyback

By Douglas Kim

  • ATRenew (RERE US) is one of the stocks in China that is starting to look very attractive after a sharp decline in its share price since its IPO.
  • ATRenew has achieved noticeable improvements in operations and profitability in the recent quarter.
  • Our base case valuation analysis suggests an implied market cap of US$720 million, representing an implied price of US$3.15 per share, representing an upside of 43% from current price.

NTGR: Routing Thru Investor Day

By Hamed Khorsand

  • NTGR held its annual investor day reflecting on the challenges it has incurred within retail and highlighting how consumer demand has remained strong for high-end devices and its 5G hotspot
  • NTGR’s stock has been trading at levels valuing the Company near its working capital on fears the business would continue to generate losses
  • NTGR’s transition in becoming a super-premium brand started over a year ago, but only in recent quarters has it began to take a bigger role on the consumer 

Taiwan Tech Weekly: Hon Hai IPhone Plant Recovery, Nanya Slumps, Intel Foundry Potential in 2023

By Vincent Fernando, CFA

  • Hon Hai’s Zhengzhou iPhone plant to return to full production? Shares pop
  • Nanya Tech shares worst performers last week – We remain near-term negative
  • Intel & TSMC trade flattish last week — Intel currently at UBS’s TMT conference

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Aneka Gas, Daifuku Co Ltd, CEL Corp and more

By | Daily Briefs, Industrials

In today’s briefing:

  • Aneka Gas (AGII IJ) – Out of Thin Air
  • Daifuku (6383) | Attractive Valuation Drivers Despite near Term Risks
  • A Profitable Japanese Microcap Trading at a 53% Discount to NCAV.

Aneka Gas (AGII IJ) – Out of Thin Air

By Angus Mackintosh

  • Aneka Gas is an interesting concept in that its product literally comes out of thin air given its position as Indonesia’s leading Industrial gas player with a 45% market share.
  • The company provides investors with wide-ranging exposure to the Indonesian economy from industry to infrastructure, consumer goods, healthcare, and SME amongst others, which also reduces risk through diversity.
  • Aneka Gas 9M2022 numbers reflected a change in revenue mix and demand for medical gas reduces post-COVID and other areas such as industry, retail, and infrastructure started to recover.

Daifuku (6383) | Attractive Valuation Drivers Despite near Term Risks

By Mark Chadwick

  • Daifuku is a growth stock that has fallen by 26% YTD reflecting near term risks to growth and margins
  • We believe that Daifuku is a major beneficiary of continued investment in automation, especially in e-commerce and logistics
  • We analyse Daifuku’s core valuation drivers and see around 16% upside for the stock

A Profitable Japanese Microcap Trading at a 53% Discount to NCAV.

By Generals and Workouts

  • The cash comes from a one-off asset sale. CEL hasn’t been building cash on the balance sheet for years. While management has no intention of paying out the cash at present, they plan to use it for acquisitions. It won’t stay on the balance sheet for ever.

  • CEL’s operating business is not a great business, but it’s not terrible either. CEL earned an average of 15% pretax on capital employed over the last three years (FY20-FY22). The operating business earns above its cost of capital, is consistently profitable and ~40% of earnings are paid out as dividends.

  • Management has a lot of skin in the game. CEL’s founder and president, Masatsugu Shinno, owns 60% of the company, which aligns his interests with shareholders.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Health Care: Sichuan Kelun Pharmaceutical, Baxter International and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Sichuan Kelun Pharmaceutical (002422.CH) – The Deal with Merck Brightens the Outlook; A Dark Horse?
  • Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers
  • Baxter International Inc.: Detailed Credit Analysis & Financial Strength Evaluation Report

Sichuan Kelun Pharmaceutical (002422.CH) – The Deal with Merck Brightens the Outlook; A Dark Horse?

By Xinyao (Criss) Wang

  • Due to huge negative policy impact, the prospects of Kelun’s traditional businesses would be lackluster. However, the deal with MSD has completely changed Kelun’s investment logic. 
  • For the two ADC drugs in the deal, there is a great chance for SKB264 to be eventually druggable. Kelun’s ADC technology is also keeping up with the times. 
  • We deep dive the valuation of Kelun. The market’s perception of Kelun is still at the level of traditional businesses. The potential of its ADC pipeline hasn’t been priced in.

Baxter International Inc.: Initiation of Coverage – Recent FDA Approvals & Other Drivers

By Baptista Research

  • This is our first report on Baxter International, one of the largest players in the domain of dialysis therapies and other healthcare products.
  • The overall demand for products across the Baxter and traditional Hillrom portfolios continues to be strong.
  • We initiate coverage on the stock of Baxter International with a ‘Buy’ rating.

Baxter International Inc.: Detailed Credit Analysis & Financial Strength Evaluation Report

By Baptista Research

  • Baxter International is a giant within the space of dialysis therapies and other healthcare products.
  • The company’s recent financial results have been decent despite the fact that sales were impacted by specific supply chain-related issues.
  • The overall demand for products across the Baxter and traditional Hillrom portfolios continues to be strong.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: Nikkei 225, Nippon Prologis Reit, Logan Property Holdings, Perella Weinberg Partners, Star Health, NFT, Binance Coin and more

By | Daily Briefs, Financials

In today’s briefing:

  • Nikkei the First to Crack
  • Nippon Prologis REIT (3283 JP): Offering Could Be a Catalyst for Outperformance Vs Peers
  • Morning Views Asia: Central China Securities, Jingrui Holdings
  • Too Big to Fail?
  • Star Health IPO Lockup – Owned by Financial Investors, US$3.0bn Worth Shares Are Well in the Money
  • Sporting Crypto – Dec 5th: The Casino and The Factory
  • Bearish Sentiment Hits Binance’s BNB Token

Nikkei the First to Crack

By Thomas Schroeder

  • Japan has been a top long in Asia, the rising wedge had us reducing our long. Friday saw a pronounced RSI bear wedge break and price crack.
  • Japan faces rotation pressure into core Asia and will shift Japan into the bear camp on a muted recovery attempt.
  • Japan’s macro cycle remains trapped in a sideways range. Buy support near 26,000 and sell resistance near 29,000.

Nippon Prologis REIT (3283 JP): Offering Could Be a Catalyst for Outperformance Vs Peers

By Janaghan Jeyakumar, CFA

  • Japan’s largest logistics REIT Nippon Prologis Reit (3283 JP) (“NPR”) announced a US$170mn follow-on equity offering to fund their recent acquisition of three logistics facilities.
  • The primary offer quantity will be 76,570 units out of which 44,410 units and 32,160 units are expected to be allocated for domestic and international investors, respectively. 
  • Below is a closer look at the details of this offering and the potential of this offering to trigger strong secondary market performance in the following weeks.

Morning Views Asia: Central China Securities, Jingrui Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Too Big to Fail?

By subSPAC

  • Investment Banks and Advisory firms have thrived over the past two years as the rapid pace of dealmaking induced by the post-pandemic era led to significant profits.
  • New York City-based Perella Weinberg Partners took advantage of the free-flowing capital market conditions by closing some of the biggest M&A deals over the last decade and choosing to list on public markets through a SPAC.
  • With all the talk of an economic slowdown going into 2023, Investment Banks are cautious heading into next year, focusing on preserving cash and switching to ancillary advisory services rather than staying on the hunt for big deals.

Star Health IPO Lockup – Owned by Financial Investors, US$3.0bn Worth Shares Are Well in the Money

By Sumeet Singh

  • In Dec 2021, Star Health (STARHEAL IN) (SHAI), the largest private health and retail health insurance company in India, raised around US$851m in its India IPO.
  • SHAI insured 20.5m people in FY21. SHAI primarily offers retail health insurance which accounted for 87.9% of its FY21 GWP. Individual agents accounted for 97% of its FY21 GWP.
  • In this note, we will talk about the upcoming lockup expiry.

Sporting Crypto – Dec 5th: The Casino and The Factory

By Sporting Crypto

  • Instead of going on a long rant about why this next iteration of NFTs is important more broadly – let’s contextualise this for the sports industry.
  • After all, this is a newsletter called Sporting Crypto.
  • The sports industry has seen some pretty amazing things when it comes to Web3.

Bearish Sentiment Hits Binance’s BNB Token

By Kaiko

  • Price Movements: The tokens for the decentralized derivatives exchanges dYdX and GMX have surged since the collapse of FTX.
  • Market Liquidity: Dollar trading volumes for BTC markets dropped to two year lows relative to Tether. 
  • Derivatives: BNB funding rates dip to their most negative this year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars